Watchlist Price Alert

Sonnet BioTherapeutics I... (SONN)

NASDAQ: SONN · Real-Time Price · USD

1.27

0.03 (2.83%)

At close: May 16, 2025, 10:17 AM

Sonnet BioTherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	149.46K	2.27M	3.05M	27.62M	7.35M	35.65K	524.11K	438.49K	268.57K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	800K	800K	800K	800K
Other Long-Term Assets	509.15K	464.19K	113.28K	-182.27K	82.96K	446.64K	2.86M	490.33K	442.74K
Receivables	n/a	786.57K	n/a	n/a	n/a	n/a	325.36K	475.99K	524.48K
Inventory	n/a	n/a	-717.3K	n/a	n/a	478.31K	335.21K	460.76K	539.55K
Other Current Assets	1.21M	1.68M	2.36M	1.19M	287.74K	n/a	159.21K	589.84K	461.07K
Total Current Assets	2.12M	4.74M	5.41M	28.81M	7.64M	39.75K	1.34M	1.8M	1.79M
Property-Plant & Equipment	143.94K	227.06K	302.81K	182.27K	273.81K	10.47M	9.76M	8.55M	11.51M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	16.4M	25.6M	31.19M	31.34M
Total Long-Term Assets	653.09K	691.25K	416.08K	182.27K	356.77K	28.12M	28.45M	28.38M	31.69M
Total Assets	2.77M	5.43M	5.83M	28.99M	7.99M	39.75K	29.79M	30.18M	33.49M
Account Payables	2.18M	2.2M	4.75M	3.78M	2.06M	1.84M	2.38M	3.68M	3.81M
Deferred Revenue	n/a	18.63K	166.43K	516.37K	500K	1.17M	1.17M	83.88K	173.78K
Short-Term Debt	n/a	n/a	748.00	748.00	21.18K	217.38K	6.66M	8.74M	6.38M
Other Current Liabilities	792.69K	1.14M	1.98M	1.32M	1.42M	n/a	3.97M	2.4M	1.67M
Total Current Liabilities	3.21M	5.52M	8.16M	6.7M	4.72M	2.89M	13.03M	14.73M	12.11M
Long-Term Debt	n/a	n/a	n/a	n/a	124.88K	n/a	3.67M	852.38K	3.97M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	-102.3K	3.58M	2.16M	1.96M
Total Long-Term Liabilities	46.57K	130.86K	203.91K	30.61K	250.01K	7.22M	8.51M	3.96M	7.41M
Total Liabilities	3.26M	5.66M	8.37M	6.73M	4.97M	2.89M	21.54M	18.69M	19.52M
Total Debt	130.86K	203.91K	255.99K	125.88K	353.25K	217.38K	10.34M	9.59M	10.35M
Common Stock	65.00	175.00	554.00	6.03K	1.47K	555.00	373.00	305.00	2.14K
Retained Earnings	-117.68M	-110.24M	-91.41M	-61.69M	-36.71M	-12.44M	-57.12M	-49.11M	-42.21M
Comprehensive Income	n/a	-0.00	n/a	n/a	n/a	-202.12K	-202.12K	-934.9K	-1.16M
Shareholders Equity	-485.74K	-225.98K	-2.54M	22.26M	3.02M	-2.85M	7.43M	10.71M	12.82M
Total Investments	n/a	n/a	n/a	n/a	n/a	800K	800K	800K	800K